We understand that disease-modifying anti-rheumatic drugs and other biological treatments including Etanercept is vitally important to many people in this country. Our contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the European Union, such as precautionary stockpiling by suppliers, to ensure that the supply of essential medicines to patients is not disrupted.